Early experience with CELT ACD vascular access closure device for neurointerventional procedures.

INTRODUCTION

The CELT ACD (Vasorum Ltd, Dublin, Ireland) is an access closure device achieving hemostasis with a steel radiopaque structure deployed into the arterial wall without sheath exchange. There is limited data regarding its use in neurointerventional procedures, particularly with larger arteriotomies.

METHODS

A prospective registry of neurointerventional procedures at a single center between July 2024 and February 2025 was retrospectively reviewed. Consecutive transfemoral cases with 6, 7, and 8F sheaths undergoing closure with a newly-deployed 6 or 7F CELT were included. The primary outcomes were rates of device failure and access site complications.

RESULTS

Of 116 patients, there were 119 CELT closures. Successful deployment occurred in 98.3% (117/119). Other than a small groin hematoma (0.8%; 1/119), there were no other access site-related complications reported.

CONCLUSION

This early experience suggests favorable performance and minimal complications with CELT in neurointerventional procedures with larger arteriotomies.